FDA Inspection
McLaren Northern MichiganMcLaren Northern Michigan – FDA Inspection, Aug 4, 2026
Record Details
This FDA Inspection record concerns McLaren Northern Michigan, with an inspection on August 4, 2026, issued by the Detroit District Office, covering biologics.
View Company Profile
ID · 73c6abd5-d4a3-425a-844b-7c90a59e4280
Inspection Facts
- Inspection number
- 1329420
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of McLaren Northern Michigan
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 24, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 5, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 14, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 2, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for McLaren Northern Michigan
- FDA Inspection 1097340 - 2019-06-12
- FDA Inspection 1025480 - 2017-08-24
- FDA Inspection 929603 - 2015-06-05
- FDA Inspection 811305 - 2012-12-14
- FDA Inspection 701383 - 2010-12-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.